Neuland Laboratories Ltd.

Financial

	Neuland Laboratories	Gufic Biosciences	Glenmark Life Scienc
Operational Metrics
API Sector
US DMF Filings	66.0 .	n/a	502.0 .
Global DMFs filed	972.0 .	n/a	n/a
Pharmaceutical Sector
R&D as a % of Total Sales	2.53 %	1.06 %	3.2 %
Financials
5 yr Average ROE	7.78 %	26.14 %	77.76 %
5yr average Equity Multiplier	1.65	2.82	5.38
5yr Average Asset Turnover Ratio	0.67	1.1	0.75
5yr Avg Net Profit Margin	6.73 %	9.03 %	20.48 %
Price to Book	7.91	8.41	4.28
P/E	28.26	39.03	21.18
5yr Avg Cash Conversion Cycle	64.68 Days	-18.02 Days	87.84 Days
Inventory Days	94.42 Days	77.22 Days	90.19 Days
Days Receivable	91.33 Days	81.36 Days	124.34 Days
Days Payable	114.5 Days	175.58 Days	103.85 Days
5yr Average Interest Coverage Ratio	7.45	10.3	313.94
5yr Avg ROCE	11.07 %	33.27 %	95.75 %
5yr Avg Operating Profit Margin	15.88 %	17.37 %	30.33 %
5 yr average Debt to Equity	0.26	0.73	0.0
5yr CAGR Net Profit	58.32 %	29.43 %	19.01 %
5yr Average Return on Assets	4.76 %	10.17 %	15.3 %
Shareholdings
Promoter Holding	32.74 %	72.51 %	82.85 %
Share Pledged by Promoters	0.0	0.0	9.47 %
Change in Promoter Holding (3 Yrs)	-3.48 %	6.76 %	0.01 %
Change in Mutual Fund Holding (3 Yrs)	3.01 %	-6.16 %	0.63 %

Business

	Neuland Laboratories	Gufic Biosciences	Glenmark Life Scienc
Product Wise Break-Up	Product Wise Break-Up Custom Manufacturing Solutions(CMS) 55.0 Formulations 42.0 API 0 Muscle Relaxants 0 Cardiovascular 0 Proton pump inhibitors 0 Anti-fungals 0 Anti-bacterials 0 International 0 CMO 0 Domestic 0 API`s 0 CDMO 0 Generic API 0 Others 3.0	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 5.0 Cardiovascular 0 Domestic Pharmaceuticals 50.0 CMO 30.0 API`s 0 Generic API 0 Anti-bacterials 0 Proton pump inhibitors 0 International 15.0 Custom Manufacturing Solutions(CMS) 0 CDMO 0 Formulations 0 Anti-fungals 0 Muscle Relaxants 0	Product Wise Break-Up API 0 Cardiovascular 0 Domestic 0 CMO 0 API`s 0 Generic API 89.12 Anti-bacterials 0 Proton pump inhibitors 0 International 0 Custom Manufacturing Solutions(CMS) 0 CDMO 6.2 Formulations 0 Anti-fungals 0 Muscle Relaxants 0 Others 4.68
Location Wise Break-Up	Location Wise Break-Up USA 31.41 Europe 30.97 India 25.14 Rest of the World 12.48 South America 0 Australia 0 North America 0 Asia 0 Africa 0	Location Wise Break-Up Europe 4.26 Africa 1.94 North America 1.68 India 84.52 Asia Pacific 7.41 Australia 0.08 South America 0.11 Rest of the World 0 USA 0	Location Wise Break-Up Europe 0 Africa 0 North America 0 India 52.43 Asia 0 Australia 0 South America 0 Rest of the World 0 USA 0 Others 47.57
Therapeutic Area Break-Up	Therapeutic Area Break-Up Anti-bacterial 19.72 Antidepressant 11.8 Anticonvulsant 10.46 Pain Management 0 Diabetes 0 CNS 0 CVS 0 Others 58.02	-	Therapeutic Area Break-Up Anti-bacterial 0 Anticonvulsant 0 CVS 43.0 Antidepressant 0 Diabetes 5.0 CNS 15.0 Pain Management 6.0 Others 31.0
Asset Break-Up	Asset Break-Up India 100.0	-	-

Neuland Laboratories Ltd.

SIGN UP FOR FREE